Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. - Wikidata - wikimedia - TriplyDB

Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.

Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q37696578

about

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis Recent Insights into the HIV/AIDS Pandemic.Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.Evaluating Adherence to Antiretroviral Therapy Using Pharmacy Refill Records in a Rural Treatment Site in South Africa Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.What's new for antiretroviral treatment in women with HIV Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria Total daily pill burden in HIV-infected patients in the southern United States.HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.Evaluation of the occurrence and type of antiretroviral and opportunistic infection medication errors within the inpatient setting Retention in care and medication adherence: current challenges to antiretroviral therapy success.MedMinify: An Advice-giving System for Simplifying the Schedules of Daily Home Medication Regimens Used to Treat Chronic Conditions.Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy.Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study.Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012 Investigational reverse transcriptase inhibitors for the treatment of HIV.Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort Use of Compassionate Supply of Antiretroviral Drugs to Avoid Treatment Interruptions or Delayed Treatment Initiation among HIV-Positive Patients Living in Ontario: A Retrospective Review.Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study.Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study

P2860

Q26778450-62E3FC91-FB28-4ECB-95D8-A0F6FE1F569A Q26783253-B140E96F-37DC-4843-819C-66FD2CFED731 Q26851448-C71D9C95-E92D-4B99-A70A-B096731BFD67 Q26865049-0F25A7F7-AE05-46BE-8331-E11F4E7F2EDA Q28081677-CAFCC542-2DBE-47C3-A829-6341D635F50B Q30235024-CD44FDD3-2768-4177-9720-8C8812869D5C Q30239741-08D5B004-B1E7-4E9C-AD70-F9A132346FD7 Q30253049-44D14E33-C51C-4D20-9FC2-13E90A93A748 Q30363571-09ED05C5-9066-4FC6-8AF5-B1F1232E28A1 Q30391322-911CFA3A-FACD-46BC-B189-B6F6C6684DF0 Q33621206-B0843CD2-E2A7-464E-96C0-13C53AD8292C Q33680234-F93D204C-F17E-4252-AA21-A0EB3DB45DC4 Q33787631-AA81486C-DB07-4C81-B4D1-76F1F19A60AD Q33803319-C2F21D0A-BD35-49F7-A770-178FFB91473D Q33866579-C759C212-3154-42A0-976F-0C69BA2C0AF5 Q34269272-EABEA2CA-C452-46E2-9681-D9594F85F3D9 Q34598681-829D8999-FFDF-4CF2-86DC-DB49D2CFD4E2 Q34976284-6FC2ADDC-BCDD-486D-8621-833B4AD52E80 Q35023687-9DF2CFCC-749A-44EE-8D92-E1CB20B7C608 Q35177350-77B4646F-5B12-4FEE-8FCA-B0612B4AE155 Q35257081-24A55C2B-A3A7-46EC-AFB6-182F2FA66285 Q35257824-D65ADBB9-C42B-421E-8658-4E5C7B413004 Q35570520-37D82710-B4D3-4183-BD41-43CA9B6F5B11 Q35652019-E2EF2ED9-BC7A-41F9-A0D2-71F7DF7D4143 Q35698144-F14AB984-9AE0-4072-B241-04D1EE3EFF05 Q35788408-2A834BB3-C9A2-46A1-B300-2F826A4918E4 Q35903617-E2ABC171-A783-47F6-83BC-3A7FEBD6D501 Q35975345-1992507D-5C2F-4912-AA8C-31F85480E70B Q36206941-F8B469A9-1A4B-4C8B-AE5F-20F9153D7937 Q36267762-ED65BBAF-73D9-4109-9DD7-AB47EB0F052B Q36292161-E2139E73-1E84-430B-8C8E-A9B56441FDCC Q36306231-65C03CBD-AB45-4505-856A-380DE5A6F574 Q36306986-EA024204-A285-4E43-A89A-8265DDF988E6 Q36479518-5A67415F-FF59-4D86-956C-F464539DDB32 Q36497865-0FC9C010-D4AA-4A19-AC34-6798BCA64518 Q36565336-25D61F1B-6ED2-46E7-8F31-415A425BB3F5 Q36602040-C3240D46-6249-4F8F-BF9C-1BC35FB1EDAC Q36635714-EA4ECFE1-0D70-453D-8419-DFC15B3D910F Q36715193-6B4081EB-5A47-4BB5-9B6D-1B3A3EA77F1A Q36765588-3B35A935-2CEF-4941-B4FD-09F99DBEFFD7

P2860

Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.

http://www.wikidata.org/entity/Q37696578

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lower pill burden and once-dai ...... randomized controlled trials.

@en

Lower pill burden and once-dai ...... randomized controlled trials.

@nl

type

label

Lower pill burden and once-dai ...... randomized controlled trials.

@en

Lower pill burden and once-dai ...... randomized controlled trials.

@nl

prefLabel

Lower pill burden and once-dai ...... randomized controlled trials.

@en

Lower pill burden and once-dai ...... randomized controlled trials.

@nl

P1433

Q37696578-025F12BF-73E2-4280-8774-36E0CE0AFC32

P1476

Q37696578-B7EA06D8-E82B-4AAA-8658-4010853C1A58

P2093

Q37696578-354CCC36-3A9B-4B66-84C6-C949E42B1A44

Q37696578-3E8DD0CD-1B94-4C73-841D-C3483EE82B1E

Q37696578-44BCF6DE-976A-45DC-9980-BFF15D506D7E

Q37696578-4ED22C1A-E473-443B-A70D-4D4A1968CB1B

Q37696578-58EECD71-9BED-46A5-B950-30D47B0BA8C2

Q37696578-A32BD371-9613-4139-A5A0-1DAE29A902E6

Q37696578-D8888FFC-9E6C-4E52-BD60-E5530A74C0F4

P2860

Q37696578-02D7AD8E-AD3A-45F2-B6F9-C2693450FB42

Q37696578-05272A25-278B-49E5-8BA7-B312BBE2E889

Q37696578-0C69449D-AA74-4965-B50E-AE664930850F

Q37696578-0F611700-0B56-4109-849E-DD7C98E3E90E

Q37696578-13B71028-FC49-4C6B-AD21-CEC91F7D923E

Q37696578-18EEBA27-A6EF-4D8A-8796-D50D981D5E54

Q37696578-1F6A2A39-E59E-4F9D-97B8-0205D3AABE44

Q37696578-2447C331-3AD1-462A-B0F2-1FF3FF973536

Q37696578-295B0FC2-ED60-4819-8E54-11ACC4B5587E

Q37696578-327AAE58-2F08-499C-9D21-37F322C791C3

P304

Q37696578-96F76CF7-7C8E-4E5A-88BA-136BDECCB6A7

P31

Q37696578-3dca280a-26a3-4b39-a3ac-623ba33bfa8d

Q37696578-6ECC6A42-8F35-47F5-BAA3-A6B7C64DEFEA

P356

Q37696578-07B41846-698C-4DA0-9266-30D20D2A226A

P407

Q37696578-0ADAC64B-F997-4367-BD67-17766CB2CF41

P433

Q37696578-5C393E11-52CF-484F-876B-51735BC88A41

P478

Q37696578-B79EB053-E2EC-45D6-B0C6-CFF914EB836D

P50

Q37696578-517E47DE-847E-480F-BD0D-00A415444F58

Q37696578-54BF8FB5-13AA-466C-A945-62B03C6DE8F2

Q37696578-EC6D98B5-29C2-460E-A91A-84024C90C0BD

P577

Q37696578-7AD4E074-0C35-49B2-AF38-F6D9D6BC3DDA

P5875

Q37696578-CCDDCBEB-219D-40EF-83BF-D0540B436CAD

P698

Q37696578-CE6941C2-7B9A-4FC2-9284-80964849697D

P921

Q37696578-6A4C459B-58DE-49F5-9981-B5D43D0E07CD

Q37696578-B37B6D33-00E3-47FD-ACFC-B5E553DAF2F9

Q37696578-E9E9A001-2AA7-4E97-AE1C-0D3810629EC5

P932

Q37696578-344D5720-8BAC-474F-AD8F-E122247A944F

P356

P1433

Clinical Infectious Diseases

P1476

Lower pill burden and once-dai ...... randomized controlled trials.

@en

P2093

David W Dowdy

http://www.w3.org/2001/XMLSchema#string

Edward J Mills

http://www.w3.org/2001/XMLSchema#string

Jean B Nachega

http://www.w3.org/2001/XMLSchema#string

Joel E Gallant

http://www.w3.org/2001/XMLSchema#string

Michael J Mugavero

http://www.w3.org/2001/XMLSchema#string

Paul E Sax

http://www.w3.org/2001/XMLSchema#string

Robert Gross

http://www.w3.org/2001/XMLSchema#string

P2860

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

Sequential methods for random-effects meta-analysis

Estimating the mean and variance from the median, range, and the size of a sample

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators

P304

1297-1307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIU046

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Thomas P. Giordano

Olalekan A. Uthman

Jean-Jacques Parienti

P577

2014-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259881995

http://www.w3.org/2001/XMLSchema#string

P698

24457345

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3982838

http://www.w3.org/2001/XMLSchema#string